Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Paolo Calabresi(Università Cattolica del Sacro Cuore), Veronica Ghiglieri(Agostino Gemelli University Polyclinic)
Cited by 710
Related Papers
Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity
|Journal of Neuroscience|2000|331
Levodopa in Parkinson’s Disease: Current Status and Future Developments
|Current Neuropharmacology|2017|276